Results 51 to 60 of about 108,295 (308)

Advances and challenges in cirrhosis and portal hypertension [PDF]

, 2017
Background Liver cirrhosis is the fourth cause of death in adults in Western countries, with complications of portal hypertension being responsible for most casualties.
Annalisa Berzigotti, Berzigotti, Annalisa   +1 more
core   +1 more source

Association of blood cadmium levels with all-cause and cause-specific mortality among adults with non-alcoholic fatty liver disease: a prospective cohort study

Frontiers in Public Health
BackgroundCadmium (Cd) accumulates in the body over time, damaging organs such as the liver, kidneys, and brain. Some researchers have suggested that elevated blood Cd levels may contribute to the onset and progression of nonalcoholic fatty liver disease
Congxi Xu, Congxi Xu, Zhi Li, Shirui Hao, Jian Zhang, Jinlong Li, Kuopeng Liang, Xiaojuan Wang, Yi Zhang, Yi Zhang, Guangyuan Zhao, Mengyun Bai, Dengxiang Liu, Jitao Wang   +13 more
doaj   +1 more source

Pathophysiology and therapeutic options for cirrhotic portal hypertension. [PDF]

Portal hypertension represents the primary non-neoplastic complication of liver cirrhosis and has life-threatening consequences, such as oesophageal variceal bleeding, ascites, and hepatic encephalopathy.
Guixé-Muntet, Sergi, Gracia-Sancho, Jordi, Quesada-Vázquez, Sergio   +2 more
core   +1 more source

Apelin signaling modulates splanchnic angiogenesis and portosystemic collateral vessel formation in rats with portal hypertension [PDF]

, 2009
BACKGROUND/AIMS: Angiogenesis is a pathological hallmark of portal hypertension. Although VEGF is considered to be the most important proangiogenic factor in neoangiogenesis, this process requires the coordinated action of a variety of factors ...
Berzigotti, Annalisa, de Gottardi, Andrea, Tiani, Carolina, Bosch, Jaime, Fernandez, Mercedes, Garcia-Pras, Ester, Mejias, Marc   +6 more
core   +1 more source

Effect of skeletal muscle index on post-embolization syndrome of hepatocellular carcinoma after transarterial chemoembolization

BMC Gastroenterology
Background Skeletal muscle index (SMI) is a commonly used research method for evaluating muscle mass.However, its impact on post-embolization syndrome(PES) of patients with hepatocellular carcinoma (HCC) undergoing transarterial chemoembolization (TACE ...
Xiaojuan Wang, Jitao Wang, Jinlong Li, Kuopeng Liang, Shoufang Dai, Ruikun Wang, Yi Zhang, Quan Ren, Linglei Meng, Yuzi Qiu   +9 more
doaj   +1 more source

The peculiarities of macroscopic status of the upper gastrointestinal tract mucosa in patients with hepatic and extrahepatic portal hypertension.

Medičnì Perspektivi, 2018
Identification of endoscopic signs of concomitant pathology of the upper gastrointestinal tract allows to determine the tactics of managing patients with different forms of portal hypertension (PG).
Yu. M. Stepanov, N. V. Chaliy, O. V. Simonova   +2 more
doaj   +1 more source

Paneth Cells Regulate Lymphangiogenesis under Control of Microbial Signals during Experimental Portal Hypertension [PDF]

, 2022
Intestinal microbiota can modulate portal hypertension through the regulation of the intestinal vasculature. We have recently demonstrated that bacterial antigens activate Paneth cells (PCs) to secrete products that regulate angiogenesis and portal ...
Esther Caparrós, Keller, Irene, Witold Wolski, Wolski, Witold, Martínez, Sebastián, Irene Keller, Martínez-López, Sebastián, Paolo Nanni, Nanni, Paolo, Sebastián Martínez-López, Francés, Rubén, Mohsin Hassan, Hassan, Mohsin, Juanola, Oriol, Mohsin, Hassan, Rubén Francés, Moghadamrad, Sheida, Caparrós, Esther, Oriol Juanola, Sheida Moghadamrad   +19 more
core   +1 more source

Gut Microbiota, Immunity, and Metabolism in the Progression From Chronic Liver Disease to Hepatocellular Carcinoma

Advanced Science, EarlyView.
This review explains how chronic liver injury progresses toward hepatocellular carcinoma through interconnected changes in gut microbes, metabolism, immunity, fibrosis, and diet. It highlights microbial metabolites, bile‐acid signaling, immune dysfunction, and nutritional or microbiome‐based interventions as opportunities to identify risk earlier ...
Yi Hu, Caiyan Lin, Lijie Zhang, Xue Jiang, Huawen Li, Yangzhe Wu   +5 more
wiley   +1 more source

Immunogenicity and safety of a booster COVID‐19 vaccination in patients with chronic liver disease: A multicenter study

Portal Hypertension & Cirrhosis, 2023
Aim Patients with chronic liver disease (CLD), especially cirrhosis, are at a high risk of severe illness or death from coronavirus disease‐2019 (COVID‐19) and may have a suboptimal immune response to the severe acute respiratory syndrome coronavirus 2 ...
Jitao Wang, Jingwen Ai, Huiling Xiang, Yanliang Zhang, Zhiyun Hou, Qiran Zhang, Jiaojian Lv, Shubo Chen, Chuan Liu, Qianqian Li, Jing Liang, Faren Xie, Shujun Jiang, Nina Zhang, Aiguo Zhang, Xiaolin Lan, Xuying Zhang, Jinlong Li, Dengxiang Liu, Wenchuan Wang, Wei Rao, Zhang Qun, Qiuju Tian, Xiaolong Qi, Wenhong Zhang   +24 more
doaj   +1 more source

Portal Hypertension in Children [PDF]

, 2016
Portal hypertension is defined as an increase of blood pressure in the portal venous bed beyond the physiological values. In childhood it is usually caused by an increase of resistance to the blood flow from the mesenteric venous circulation through ...
Neil Di Salvo, Michela Maffi, Mario Lima, Di Salvo, Neil, Maffi, Michela, Lima, Mario   +5 more
core   +1 more source